Home › Cardiovascular Disease › California › San Diego
Cardiovascular Disease clinical trials in San Diego, CA
15 studies for Cardiovascular Disease are looking for participants at sites in and around San Diego (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
RecruitingPhase 4
- Kaiser Permanente - San Diego, San Diego
- San Diego Cardiac Center, San Diego
A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
RecruitingPhase 1
- University of California, San Diego, San Diego
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Acclaim Clinical Research, San Diego
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
RecruitingPhase 3
- UCSD - Altman Clinical and Translational Research Institute (ACTRI), La Jolla · 11 mi away
Product Surveillance Registry
RecruitingObservational study
- San Diego, San Diego
- La Jolla, La Jolla · 11 mi away
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, San Diego
- Clinical Trial Site, La Jolla · 11 mi away
Zenith® Fenestrated+ Clinical Study
Recruiting
- UC San Diego, La Jolla · 11 mi away
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Recruiting
- Scripps Memorial Hospital, La Jolla · 11 mi away
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
RecruitingPhase 3
- University of California San Diego, San Diego
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
RecruitingPhase 4Healthy volunteers welcome
- VA San Diego Medical Center, San Diego
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, San Diego
- Research Site, San Diego
- Research Site, La Jolla · 11 mi away
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
RecruitingPhase 3
- Alliance Clinical Research, San Diego
- University of California San Diego, La Jolla · 11 mi away
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Recruiting
- Scripps Health, San Diego
Enhancing Capacity in Churches to Implement PA Programs
RecruitingHealthy volunteers welcome
- San Diego State University Research Foundation, San Diego
Implementing Food Referrals for Equity and Sustained Health
RecruitingPhase 2Healthy volunteers welcome
- Rady Children's Hospital San Diego, San Diego
Cardiovascular Disease trials in other cities
- Boston, MA37 studies
- New York City, NY33 studies
- Washington, DC28 studies
- Houston, TX24 studies
- Dallas, TX23 studies
- Cleveland, OH22 studies
- Atlanta, GA22 studies
- Chicago, IL21 studies
- Philadelphia, PA21 studies
- Pittsburgh, PA20 studies
- St. Louis, MO20 studies
- Nashville, TN18 studies
Other studies in San Diego
- Non-Small Cell Lung Cancer48 studies
- Breast Cancer41 studies
- Cancer (all types)32 studies
- Prostate Cancer31 studies
- Metastatic Cancer30 studies
- Colorectal Cancer25 studies
- Ovarian Cancer24 studies
- Pancreatic Cancer24 studies
- Lung Cancer23 studies
- Obesity23 studies
- Heart Failure23 studies
- Depression21 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.